Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Vitamin K: key vitamin in controlling vascular calcification in chronic kidney disease.

Schurgers LJ.

Kidney Int. 2013 May;83(5):782-4. doi: 10.1038/ki.2013.26.

PMID:
23633049
2.

Dietary vitamin K and therapeutic warfarin alter the susceptibility to vascular calcification in experimental chronic kidney disease.

McCabe KM, Booth SL, Fu X, Shobeiri N, Pang JJ, Adams MA, Holden RM.

Kidney Int. 2013 May;83(5):835-44. doi: 10.1038/ki.2012.477. Epub 2013 Jan 23.

PMID:
23344475
3.

Warfarin induces cardiovascular damage in mice.

Krüger T, Oelenberg S, Kaesler N, Schurgers LJ, van de Sandt AM, Boor P, Schlieper G, Brandenburg VM, Fekete BC, Veulemans V, Ketteler M, Vermeer C, Jahnen-Dechent W, Floege J, Westenfeld R.

Arterioscler Thromb Vasc Biol. 2013 Nov;33(11):2618-24. doi: 10.1161/ATVBAHA.113.302244. Epub 2013 Aug 29.

4.

Research progress of warfarin-associated vascular calcification and its possible therapy.

Zhang YT, Tang ZY.

J Cardiovasc Pharmacol. 2014 Jan;63(1):76-82. doi: 10.1097/FJC.0000000000000008. Review.

PMID:
24072176
5.

Vitamin K status and vascular calcification: evidence from observational and clinical studies.

Shea MK, Holden RM.

Adv Nutr. 2012 Mar 1;3(2):158-65. doi: 10.3945/an.111.001644. Review.

6.

Warfarin-induced artery calcification is accelerated by growth and vitamin D.

Price PA, Faus SA, Williamson MK.

Arterioscler Thromb Vasc Biol. 2000 Feb;20(2):317-27.

7.

Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial.

Westenfeld R, Krueger T, Schlieper G, Cranenburg EC, Magdeleyns EJ, Heidenreich S, Holzmann S, Vermeer C, Jahnen-Dechent W, Ketteler M, Floege J, Schurgers LJ.

Am J Kidney Dis. 2012 Feb;59(2):186-95. doi: 10.1053/j.ajkd.2011.10.041. Epub 2011 Dec 9.

PMID:
22169620
8.

[Vascular calcifications and vitamin K deficiency: a modifiable risk factor in chronic kidney disease].

Phan O, Burnier M.

Rev Med Suisse. 2013 Feb 27;9(375):451-2, 454-5. Review. French.

PMID:
23539811
9.

Prevention of vasculopathy by vitamin K supplementation: can we turn fiction into fact?

Brandenburg VM, Schurgers LJ, Kaesler N, Püsche K, van Gorp RH, Leftheriotis G, Reinartz S, Koos R, Krüger T.

Atherosclerosis. 2015 May;240(1):10-6. doi: 10.1016/j.atherosclerosis.2015.02.040. Epub 2015 Feb 24. Review.

PMID:
25744701
10.

Vascular calcification: the price to pay for anticoagulation therapy with vitamin K-antagonists.

Chatrou ML, Winckers K, Hackeng TM, Reutelingsperger CP, Schurgers LJ.

Blood Rev. 2012 Jul;26(4):155-66. doi: 10.1016/j.blre.2012.03.002. Epub 2012 Apr 18. Review.

PMID:
22520397
11.

[Vitamin K, bone metabolism and vascular calcification in chronic kidney disease].

Zak-Gołab A, Okopień B, Chudek J.

Przegl Lek. 2011;68(9):629-32. Review. Polish.

PMID:
22335014
12.

Vitamin K2 supplementation in haemodialysis patients: a randomized dose-finding study.

Caluwé R, Vandecasteele S, Van Vlem B, Vermeer C, De Vriese AS.

Nephrol Dial Transplant. 2014 Jul;29(7):1385-90. doi: 10.1093/ndt/gft464. Epub 2013 Nov 26.

PMID:
24285428
13.

Post-translational modifications regulate matrix Gla protein function: importance for inhibition of vascular smooth muscle cell calcification.

Schurgers LJ, Spronk HM, Skepper JN, Hackeng TM, Shanahan CM, Vermeer C, Weissberg PL, Proudfoot D.

J Thromb Haemost. 2007 Dec;5(12):2503-11. Epub 2007 Sep 10.

PMID:
17848178
14.

The role of vitamin K in soft-tissue calcification.

Theuwissen E, Smit E, Vermeer C.

Adv Nutr. 2012 Mar 1;3(2):166-73. doi: 10.3945/an.111.001628. Review.

15.

Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization.

Schurgers LJ, Uitto J, Reutelingsperger CP.

Trends Mol Med. 2013 Apr;19(4):217-26. doi: 10.1016/j.molmed.2012.12.008. Epub 2013 Jan 30. Review.

PMID:
23375872
16.

Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats.

Schurgers LJ, Spronk HM, Soute BA, Schiffers PM, DeMey JG, Vermeer C.

Blood. 2007 Apr 1;109(7):2823-31.

17.

Bleeding, vertebral fractures and vascular calcifications in patients treated with warfarin: hope for lower risks with alternative therapies.

Fusaro M, Crepaldi G, Maggi S, D'Angelo A, Calo L, Miozzo D, Fornasieri A, Gallieni M.

Curr Vasc Pharmacol. 2011 Nov;9(6):763-9. Review.

PMID:
21623708
18.

Long-term proton pump inhibitor use is associated with vascular calcification in chronic kidney disease: a cross-sectional study using propensity score analysis.

Fusaro M, Noale M, Tripepi G, Giannini S, D'Angelo A, Pica A, Calò LA, Miozzo D, Gallieni M.

Drug Saf. 2013 Aug;36(8):635-42. doi: 10.1007/s40264-013-0062-6.

PMID:
23670724
19.

[Vascular calcification: a common but overlooked condition].

Stenvinkel P.

Lakartidningen. 2013 May 22-28;110(21):1041-4. Review. Swedish. No abstract available.

PMID:
23805771
20.

Vitamin K1 to slow vascular calcification in haemodialysis patients (VitaVasK trial): a rationale and study protocol.

Krueger T, Schlieper G, Schurgers L, Cornelis T, Cozzolino M, Jacobi J, Jadoul M, Ketteler M, Rump LC, Stenvinkel P, Westenfeld R, Wiecek A, Reinartz S, Hilgers RD, Floege J.

Nephrol Dial Transplant. 2014 Sep;29(9):1633-8. doi: 10.1093/ndt/gft459. Epub 2013 Nov 26.

PMID:
24285427
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk